Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Yasmin, F. Najeeb, H. Moeed, A. Naeem, U. Asghar, M. S. Chughtai, N. U. Yousaf, Z. Seboka, B. T. Ullah, I. Lin, C. Y. Pakpour, A. H.

COVID-19 Vaccine Hesitancy in the United States: A Systematic Review

  • Americas
  • United States of America
  • All age groups
  • Healthcare workers
  • Pregnant women
  • Parents/caregivers
  • COVID-19
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Sallam, M.

Covid-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Gong, Inna Vijenthira, Abi Betschel, Stephen Hicks, Lisa K. Cheung, Matthew

COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Bilotta, C. Perrone, G. Adelfio, V. Spatola, G. F. Uzzo, M. L. Argo, A. Zerbo, S.

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Gonzalez Rodriguez, P. Perez-Moneo Agapito, B. Albi Rodriguez, M. S. Aizpurua Galdeano, P. Aparicio Rodrigo, M. Fernandez Rodriguez, M. M. Esparza Olcina, M. J. Ochoa Sangrador, C. en representacion del Grupo de Trabajo de Pediatria Basada en la Evidencia de la, A. E. P. y AEPap

COVID-19: Critical appraisal of the evidence

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Cavanna, L. Citterio, C. Toscani, I.

Covid‐19 vaccines in cancer patients. Seropositivity and safety. systematic review and meta‐analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ishiwada, N.

Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan

  • Western Pacific
  • Japan
  • All age groups
  • Pneumococcal disease
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Odone, A. Dallagiacoma, G. Frascella, B. Signorelli, C. Leask, J.

Current understandings of the impact of mandatory vaccination laws in Europe

  • Europe
  • Healthcare workers
  • All age groups
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Somefun, O. D. Casale, M. Haupt Ronnie, G. Desmond, C. Cluver, L. Sherr, L.

Decade of research into the acceptability of interventions aimed at improving adolescent and youth health and social outcomes in Africa: a systematic review and evidence map

  • Africa
  • Adolescents
  • Adults
  • Low and Middle Income Countries
  • Human papillomavirus (HPV)
  • HIV / AIDS
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Okoli, G. N. Racovitan, F. Abdulwahid, T. Hyder, S. K. Lansbury, L. Righolt, C. H. Mahmud, S. M. Nguyen-Van-Tam, J. S.

Decline in Seasonal Influenza Vaccine Effectiveness with Vaccination Program Maturation: A Systematic Review and Meta-analysis

  • All age groups
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...